The orthobiologics market was valued at USD 7.09 Billion in 2025 and is expected to grow at a CAGR of 5.40%, reaching USD 12.00 Billion by 2035. The market is propelled by increasing adoption of biologic solutions for musculoskeletal injuries and orthopedic procedures.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
5.4%
Value in USD Billion
2026-2035
*this image is indicative*
Region-wise, North America is expected to be the leading market for orthobiologics in the forecast period of 2026-2035. This could be attributed to the prevalence of prominent players who promote quality care and regularly update strategies for product development. Furthermore, reimbursement policies and fusion enhancement products, combined with robust healthcare industry, has been propelling the market forward. Meanwhile, the market for orthobiologics is expected to grow at an exponential rate in the Asia Pacific region in the forecast period. Increasing awareness, both among doctors and patients of the benefits of these products, rising disposable incomes, and improving healthcare standards help grow the regional market. Enhancement of the healthcare infrastructure in the forecast period is expected to provide growth opportunities in the forecast period. Also, growing competition among key players leading to increasing product launches is also driving the market for orthobiologics forward.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Orthobiologics are substances that orthopaedic surgeons use to help and catalyse healing. Healing of broken bones and injured muscles, tendons, and ligaments are few of the areas these are used in. Orthobiologics consist of substances that naturally occur in the human body.
Breakup by Product
Breakup by Type
Breakup by Application
Breakup by End Use
Breakup by Region
Hip and knee replacement is expected to have risen and is expected to rise significantly in the coming years, being one of the main drivers of orthobiologics. Rising geriatric population and increased awareness about orthobiologics are easing the growth of this market. Hospitals are the leading market segment in terms of end use. This is due to increasing adoption of new procedures and the rise of high end as well as affordable hospitals. High patient turnaround and frequent readmissions push the segment share of hospitals. The supportive infrastructure that helps ensure the accuracy and reliability of the procedure is also driving the market forward. Further, increased investment in research and development and advanced technological innovations by the major market players is expected to push the market growth in the forecast period as well.
The report gives a detailed analysis of the following key players in the global orthobiologics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global orthobiologics market is projected to grow at a CAGR of 5.40% between 2026 and 2035.
The major drivers of the market include the increased awareness, increasing adoption of new procedures, rise of high end and affordable hospitals, supportive infrastructure, increased investment in research and development and advanced technological innovations.
Rise in hip and knee replacement cases and rising geriatric population are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The market is segmented on the basis of product into demineralized bone matrices (DBM), Visco supplementation, bone morphogenetic protein, plasma-rich protein, bone marrow aspirate concentrate, and allografts, among others.
The market is divided by type into knee, ankle, hip, wrist and shoulder, and spine, among others.
The major applications are osteoarthritis and degenerative arthritis, spinal fusion, soft-tissue injuries, fracture recovery, maxillofacial and dental applications, among others.
The end-uses are hospitals, orthopedic clinics, and ambulatory care centres, dental clinics and facilities, research and academic institute, among others.
The major players in the industry are Kuros Biosciences A.G., Bioventus LLC, Smith & Nephew Plc, Johnson & Johnson Services, Inc., and Stryker Corporation, among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share